As a direct response from client feedback, BSI launches a new speed-to-market program, CE-Onsite FastTrack Review, for Class III medical devices needing European CE Marking Design Dossier Reviews. This new program will expedite the review process through live, onsite interaction, facilitating more efficient communication as well as the goal of completing the review in 45 working days.
The CE-Onsite has the same features of the CE-45 FastTrack Program, with one main difference: BSI Product Experts visit the manufacturer’s premises to perform the review. As an industry norm, reviews are conducted via mail, email, fax and telephone and the process can take months. However, performing reviews onsite allows for a much faster timeline while still maintaining the same high quality. This face-to-face opportunity provides Product Experts accessibility to all relevant parties, from engineers to regulators, and supports dynamic communication, immediate access to documentation and in-person viewing of the new product.
This new premium program is not for everyone or every product. As with the CE-90 and CE-45 programs, some products such as medicinal, blood and animal tissue products, require the use of outside agencies and may not be eligible for CE-Onsite Review. In addition, while BSI's goal is to complete the review with either a positive or negative recommendation within 45 working days, the length of the review greatly depends on the degree to which the manufacturer is prepared. In order to make the review as effective as possible, clients should have a strong motivation to get their product to market and excellent documentation, and be well-organized and responsive to questions. Manufacturers utilizing the CE-Onsite have experienced numerous advantages including shorter launch times, patients gaining access to new technology sooner and quicker return on investment.
"The interactive aspect of the CE-Onsite FastTrack Review compresses the review time, improves the predictability of the review's outcome, and promotes a faster time-to-market," stated Ibim Tariah, Technical Director of BSI, Healthcare. "BSI provides thorough and fair reviews that focus on what really matters, but we never guarantee a CE Marking," Tariah added. "The integrity of each review is critical to ensuring a medical device is deemed safe for its intended use."
BSI focuses on the changing marketplace and responds to arising issues with solutions that help organizations achieve their goals and objectives. We employ top-notch Product Experts who are well trained, experienced, and knowledgeable in their respective fields. They understand the medical device industry and the challenges medical device manufacturers face in today's competitive environment.
About BSI Product Services, Healthcare
BSI Product Services, Healthcare contributes to our clients’ success in the global medical device industry by accelerating access to international markets. We are a world-class Notified Body, dedicated to providing rigorous regulatory and quality management reviews and product certifications for medical device manufacturers. BSI has been conducting business in more than 100 countries for over 100 years. Our experienced healthcare team specializes in high-risk, invasive, combination and implantable products. BSI services include CE Marking, ISO 13485, CMDCAS, Japan PAL, FDA Accredited Persons Inspections, Standards and Training. We are committed to providing programs that combine speed with experience, integrity, independence and predictability.
Europe, Middle East and Africa, Naomi Prior/Judy Wakelin, BSI Group Press Office, London, UK, Email: email@example.com - Tel: +44 (0)20 8996 6330
BSI Americas, Reston VA, USA, Shereen Abuzobaa, VP of Marketing and Training, Email: firstname.lastname@example.org - Tel: +1 703 464-1931
Asia Pacific, BSI Asia Pacific, Hong Kong, Tel: + 852 2147 9891